Hospital General Universitario Gregorio Maranon HGUGM

Madrid 28007

3 studies enrolling now · 12 studies all time

What they study most

Crohn's Disease, Cutaneous Squamous Cell Carcinoma, EGFR Exon 20 Mutation, Extensive-stage Small-cell Lung Cancer, Metastatic Colon Cancer, Metastatic Colorectal Cancer, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer, Primary Biliary Cholangitis, Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis

Studies at this site

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment — Recruiting now
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis — Recruiting now
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer — Recruiting now
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease — Recruiting now
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. — Running, not enrolling
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes — Running, not enrolling
A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer — Running, not enrolling
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma — Running, not enrolling
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer — Running, not enrolling
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer — Completed